UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

AIMS: To compare the effectiveness of continuous aflibercept versus pro re nata (PRN) ranibizumab therapy for neovascular age-related macular degeneration (nAMD). METHODS: Multicentre, national electronic medical record (EMR) study on treatment naive nAMD eyes undergoing PRN ranibizumab or continuou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Ophthalmol
Autors principals: Lee, Aaron Y, Lee, Cecilia S, Egan, Catherine A, Bailey, Clare, Johnston, Robert L, Natha, Salim, Hamilton, Robin, Khan, Rehna, Al-Husainy, Sahar, Brand, Christopher, Akerele, Toks, Mckibbin, Martin, Downey, Louise, Tufail, Adnan
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673590/
https://ncbi.nlm.nih.gov/pubmed/28478396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2016-309818
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars